Mind Medicine (MindMed) Inc. – Filings and Transcripts – BamSEC

You must log in to view this page.

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement

Prospectus with selling stockholder info

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Automatic shelf registration

Ownership Filter

News Filter

Investor Presentation

MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder

MindMed Reports Third Quarter 2024 Financial Results and Business Updates

Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements or Exhibits

MindMed Reports Second Quarter 2024 Financial Results and Business Updates

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Proxy materials by non-management

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission

Letter from the SEC

Scanned paper annual report submission